Restricted Erbitux --> Restricted to outpatient oncology and inpatient head or neck cancer being treated with radiation therapy and unable to receive CISplatin.
Restricted to outpatient oncology and inpatient head or neck cancer being treated with radiation therapy and unable to receive CISplatin. For metastatic colorectal cancer, use is limited to KRAS wild type, EGFR expressing cases.
Reviewed: June 22, 2005, and 24 April 2018 (Erbitux)
Restricted to outpatient oncology and inpatient head or neck cancer being treated with radiation therapy and unable to receive CISplatin. For metastatic colorectal cancer, use is limited to KRAS wild type, EGFR expressing cases.
Reviewed: June 22, 2005, and 24 April 2018 (Erbitux)